Literature DB >> 12130441

MR cholangiopancreatography in patients with primary sclerosing cholangitis: interobserver variability and comparison with endoscopic retrograde cholangiopancreatography.

K M Vitellas1, A El-Dieb, K K Vaswani, W F Bennett, M Tzalonikou, C Mabee, R Kirkpatrick, J G Bova.   

Abstract

OBJECTIVE: The purpose of our study was to determine the degree of interobserver variability and correlation between MR cholangiopancreatography and endoscopic retrograde cholangiopancreatography (ERCP) for the presence of bile duct strictures in patients with primary sclerosing cholangitis.
MATERIALS AND METHODS: For this retrospective study involving 26 patients with primary sclerosing cholangitis, 31 MR cholangiopancreatograms were compared with 30 endoscopic retrograde cholangiopancreatograms. The MR cholangiopancreatograms were independently interpreted by two abdominal radiologists in a blinded, randomized manner for overall image quality, extent of ductal visualization, and the presence and location of bile duct strictures. Unweighted multirater kappa coefficient values were estimated for each comparison.
RESULTS: Visualization of more than 50% of the expected ductal length was possible in the extrahepatic, central intrahepatic, and peripheral intrahepatic bile ducts in 99%, 88%, and 69% of the MR cholangiopancreatograms and 100%, 86%, and 52% of the endoscopic retrograde cholangiopancreatograms, respectively. Strictures were detected in the extrahepatic, central, and peripheral ducts in 53%, 68%, and 87% of the MR cholangiopancreatograms and 73%, 67%, and 63% of the endoscopic retrograde cholangiopancreatograms, respectively. The interobserver agreement for stricture detection was 61% for MR cholangiopancreatography and 76% for ERCP. MR cholangiopancreatographic findings were consistent with ERCP findings for the presence of strictures in 69% of the cases.
CONCLUSION: In patients with primary sclerosing cholangitis, MR cholangiopancreatography better shows the bile ducts and can depict more strictures, especially of the peripheral intrahepatic ducts, than ERCP. MR cholangiopancreatography can be used to noninvasively diagnose and follow up patients with primary sclerosing cholangitis.

Entities:  

Mesh:

Year:  2002        PMID: 12130441     DOI: 10.2214/ajr.179.2.1790399

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  11 in total

Review 1.  Pancreatic and biliary anomalies: imaging in 2008.

Authors:  Sudha A Anupindi
Journal:  Pediatr Radiol       Date:  2008-05

2.  Primary sclerosing cholangitis: A review and update.

Authors:  James H Tabibian; Christopher L Bowlus
Journal:  Liver Res       Date:  2017-12

Review 3.  Hepatobiliary MR imaging with gadolinium-based contrast agents.

Authors:  Alex Frydrychowicz; Meghan G Lubner; Jeffrey J Brown; Elmar M Merkle; Scott K Nagle; Neil M Rofsky; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2012-03       Impact factor: 4.813

Review 4.  Recurrence and rejection in liver transplantation for primary sclerosing cholangitis.

Authors:  Bjarte Fosby; Tom H Karlsen; Espen Melum
Journal:  World J Gastroenterol       Date:  2012-01-07       Impact factor: 5.742

Review 5.  Magnetic resonance evaluations of biliary malignancy and condition at high-risk for biliary malignancy: Current status.

Authors:  Reiji Sugita
Journal:  World J Hepatol       Date:  2013-12-27

6.  Primary sclerosing cholangitis in children: utility of magnetic resonance cholangiopancreatography.

Authors:  Govind B Chavhan; Eve Roberts; Rahim Moineddin; Paul S Babyn; David E Manson
Journal:  Pediatr Radiol       Date:  2008-06-27

Review 7.  Endoscopy in the management of primary sclerosing cholangitis.

Authors:  Mark McLoughlin; Robert Enns
Journal:  Curr Gastroenterol Rep       Date:  2008-04

8.  Gadoxetic acid-enhanced T1-weighted MR cholangiography in primary sclerosing cholangitis.

Authors:  Alex Frydrychowicz; Andrzej R Jedynak; Frederick Kelcz; Scott K Nagle; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2012-05-11       Impact factor: 4.813

9.  The best approach for diagnosing primary sclerosing cholangitis.

Authors:  Wellington Andraus; Luciana Haddad; Lucas Souto Nacif; Felipe D Silva; Roberto Blasbalg; Luiz Augusto Carneiro D'Albuquerque
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

10.  Assessment of the optimal temporal window for intravenous CT cholangiography.

Authors:  Sebastian T Schindera; Rendon C Nelson; Erik K Paulson; David M DeLong; Elmar M Merkle
Journal:  Eur Radiol       Date:  2007-07-03       Impact factor: 7.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.